SeaSpine Holdings Corporation SPNE
At closeJan 4, 2023, 4:00 PM EST
52-week range unavailable
- Market cap
- 360.18M
- Revenue (ttm)
- 229.75M
- Profit margin
- -28.22%
- Shares out
- 37.76M
- Forward P/E
- -7.57
- Volume
- 1.16M
- Open
- 8.83
- Previous close
- 9.54
- Day's range
- 8.43 – 9.67
- Beta
- 1.30
- Analysts
- Buy
- Price target
- 15.42 (+61.6%)
- Earnings date
- Nov 1, 2022
Key statistics
- Enterprise value
- 351.50M
- PEG ratio
- 1.12
- Price / sales
- 1.57
- Price / book
- 1.29
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 44.60%
- Free cash flow
- -57.94M
- Total cash
- 46.76M
- Total debt
- 43.35M
- Return on equity
- -21.57%
- Short % of float
- 1.16%
- 50-day average
- 7.27
- 200-day average
- 7.31
Analyst view
Consensus: buy
- Target (low)
- 6.75
- Target (mean)
- 15.42
- Target (high)
- 26.25
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 1, 2022
Expected Nov 1, 2022. Consensus EPS estimate -0.39.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 1, 2022 | Sep 1, 2022 | -0.30 | — | — | — |
| Aug 2, 2022 | Jun 1, 2022 | -0.35 | — | — | — |
| May 3, 2022 | Mar 1, 2022 | -0.35 | — | — | — |
| Mar 11, 2022 | Dec 1, 2021 | -0.36 | — | — | — |
| Oct 28, 2021 | Sep 1, 2021 | -0.31 | — | — | — |
| Aug 2, 2021 | Jun 1, 2021 | -0.35 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2022 | Truist Securities | down | Buy | Hold |
| Aug 3, 2022 | Piper Sandler | main | — | Overweight |
| Jul 20, 2022 | Truist Securities | main | — | Buy |
| Mar 14, 2022 | Stifel | main | — | Buy |
| Mar 14, 2022 | Piper Sandler | main | — | Overweight |
| Dec 21, 2021 | Truist Securities | main | — | Buy |
About SeaSpine Holdings Corporation
As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- seaspine.com
News
Checking If The Orthofix Merger Makes Sense For SeaSpine 
SEASPINE HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SeaSpine Holdings Corporation - SPNE 
SEASPINE HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SeaSpine Holdings Corporation - SPNE 
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing 
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing 
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FCRD, SPNE, OFIX 
SeaSpine Holdings Corp (SPNE) Q3 2022 Earnings Call Transcript 
SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates 
Earnings Scheduled For November 1, 2022 
SHAREHOLDER ALERT: Weiss Law Investigates Orthofix Medical Inc.
Your note
Sign in to keep a note on SPNE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENNY PAUL S | Officer and Treasurer | Conversion of Exercise of derivative security | Dec 29, 2022 | 20,950 |
| BOSTJANCIC JOHN J | Chief Financial Officer | Conversion of Exercise of derivative security | Dec 29, 2022 | 102,563 |
| BRADLEY KEITH | Director | Stock Award(Grant) | May 31, 2022 | 88,592 |
| CIRINO DENNIS | Officer | Conversion of Exercise of derivative security | Dec 29, 2022 | 48,556 |
| KERAN PATRICK L | General Counsel | Conversion of Exercise of derivative security | Dec 29, 2022 | 69,628 |
| LIPSCHULTZ TYLER P | Officer | Conversion of Exercise of derivative security | Dec 29, 2022 | 131,284 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Light Asset Management, LLC | 19.00% | 7,067,572 | 67.42M | Sep 29, 2022 |
| Blackrock Inc. | 6.99% | 2,601,166 | 24.82M | Sep 29, 2022 |
| Avidity Partners Management, LP | 5.40% | 2,010,000 | 19.18M | Sep 29, 2022 |
| Vanguard Group, Inc. (The) | 4.34% | 1,614,665 | 15.40M | Sep 29, 2022 |
| Emerald Advisers, LLC | 2.46% | 915,971 | 8.74M | Sep 29, 2022 |
| Driehaus Capital Management, LLC | 2.44% | 907,707 | 8.66M | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.58% | 961,674 | 9.17M | Sep 29, 2022 |
| iShares Russell 2000 ETF | 2.15% | 801,714 | 7.65M | Nov 29, 2022 |
| Vanguard Extended Market Index Fund | 1.23% | 458,508 | 4.37M | Sep 29, 2022 |
| AMG GW&K Small Cap Value Fund | 1.05% | 390,688 | 3.73M | Sep 29, 2022 |
| iShares Russell 2000 Value ETF | 1.02% | 378,613 | 3.61M | Nov 29, 2022 |
| Financial Investors Tr-Emerald Growth Fund | 1.01% | 376,035 | 3.59M | Oct 30, 2022 |